Stock-Based Compensation and Other Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2018



Activity, restricted shares: ^(a)	Restricted Shares		Per Share Weighted Average Grant Date Fair Value
Non-vested restricted shares, as of December 31, 2017	1,448,591		$	23.29
Granted	119,511		50.53
Vested	(50,966	)	22.19
Canceled/forfeited	(36,954	)	21.42
Non-vested restricted shares, as of September 30, 2018	1,480,182		$	25.57


(a)	Includes 19,300 and 27,550 restricted stock units as of September 30, 2018 and December 31, 2017, respectively.

Schedule of Employee Stock Purchase Plans

The following table provides details pertaining to the Company’s ESPPs for the periods indicated:



	For the Nine Months Ended September 30,
	2018		2017
Cash proceeds (in millions)	$	3.1	$	2.4
Common shares issued	79,459		68,789
Weighted average price per share	$	39.36	$	34.72
Weighted average per share grant date fair value	$	9.62	$	9.00

Schedule of Non-Cash Stock-Based Compensation Expense and Related Tax Effects

Details of non-cash stock-based compensation expense and related tax effects for the periods indicated were as follows (in millions):



	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2018		2017		2018		2017
Non-cash stock-based compensation expense	$	3.5	$	3.4	$	10.1	$	10.5
Income Tax Effects:
Income tax effect of non-cash stock-based compensation	$	0.9	$	1.3	$	2.7	$	3.8
Excess tax benefit from non-cash stock-based compensation ^(a)	$	0.1	$	0.0	$	0.3	$	0.1

(a)

Excess tax benefits represent cash flows from tax deductions in excess of the tax effect of compensation expense associated with share-based payment arrangements. For the nine month period ended September 30, 2018, the Company recognized a tax benefit, net of tax deficiencies, related to the vesting of share-based payment awards of $0.3 million, and for the nine month period ended September 30, 2017, recognized a tax deficiency, net of tax benefits, of $0.1 million.